AUG 26, 2016 6:42 AM PDT

Edible Battery to Power Ingestible Medical Devices

WRITTEN BY: Xuan Pham
 Ever since we were little, we’ve been told to never, ever swallow any batteries. Now, a group of engineers say they’ve developed batteries meant to be swallowed! But unlike the “AA’s” or “AAA’s” that go into toys or devices, this ingestible battery is in the form of a pill intended to power internal, ingestible medical devices.

Christopher Bettinger and his edible battery | Image: Bettinger Lab
 "For decades, people have been envisioning that one day, we would have edible electronic devices to diagnose or treat disease," said materials scientist Christopher Bettinger. "But if you want to take a device every day, you have to think about toxicity issues. That's when we have to think about biologically derived materials that could replace some of these things you might find in a RadioShack."
 
Some of the biggest challenges for having a battery inside your body is containing the chemical byproducts and preventing possible leakages of caustic agents. But even if these challenges are overcome, as they have been for pacemakers, the risk of toxicity is would be too high for devices intended to be ingested.
 
To solve this problem, Bettinger and his team at Carnegie Mellon University turned to melanin – the pigment molecule that colors our skin, hair, eyes, and gives us freckles. As it turns out, these molecules can bind and unbind metallic ions, a unique property that makes them natural batteries.
 
They then experimented with battery designs using melanin at the different terminals, and different biocompatible electrode materials, like manganese oxide, copper, and iron.

In the end, they arrived at a biocompatible, edible battery that really works. "The exact numbers depend on the configuration, but as an example, we can power a 5 milliWatt device for up to 18 hours using 600 milligrams of active melanin material as a cathode,” said Hang-Ah Park, co-researcher of the study.
 
This is enough juice to power small, ingestible devices. For example, imagine a pill that can sense the microbiome activity of your gut, or one that delivers drugs based on your body’s personal needs. This battery could power these devices, and more.
 
"The beauty is that by definition an ingestible, degradable device is in the body for no longer than 20 hours or so," Bettinger said. "Even if you have marginal performance, which we do, that's all you need."
 
It sounds like the future of “wearable devices” just got upgraded to “edible devices.”
 

Additional source: American Chemical Society via EurekAlert!
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 06, 2020
Clinical & Molecular DX
Gut Feeling: Spotting the Early Signs of Gastric Cancer
AUG 06, 2020
Gut Feeling: Spotting the Early Signs of Gastric Cancer
In a study published in Science Advances, scientists propose a new method for diagnosing gastric cancer, the third leadi ...
AUG 17, 2020
Cancer
Are Cancer Exosomes a Good Source of Biomarkers?
AUG 17, 2020
Are Cancer Exosomes a Good Source of Biomarkers?
One of cancer’s most aggravating qualities is its ability to control the microenvironment around it. This control ...
AUG 24, 2020
Clinical & Molecular DX
New Portable MRI Swoops Into Hospital Rooms, Gets FDA Nod
AUG 24, 2020
New Portable MRI Swoops Into Hospital Rooms, Gets FDA Nod
Magnetic resonance imaging, or MRI, is a medical imaging technique that uses powerful magnetic fields and radio waves to ...
SEP 16, 2020
Cancer
Does Discontinuation of Immunotherapy Effect Final Results in Metastatic Melanoma?
SEP 16, 2020
Does Discontinuation of Immunotherapy Effect Final Results in Metastatic Melanoma?
The last decade has seen the emergence of several new therapies against cancer. For melanoma, checkpoint inhibitors have ...
OCT 24, 2020
Clinical & Molecular DX
Software Flags Elevated Cerebral Palsy Risk in Premies
OCT 24, 2020
Software Flags Elevated Cerebral Palsy Risk in Premies
Diagnostic imaging scientists have developed a software tool for predicting the future onset of cerebral palsy in babies ...
NOV 12, 2020
Clinical & Molecular DX
Study Shows 1 in 5 COVID Tests Are False Positives
NOV 12, 2020
Study Shows 1 in 5 COVID Tests Are False Positives
  A study published in The BMJ has brought to light that the rapid finger-prick COVID-19 test may not be quite as r ...
Loading Comments...